Skip to main content
ILYANG PHARMACEUTICAL CO.,LTD logo

ILYANG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 007570 ISIN · KR7007570005 KO Manufacturing
Filings indexed 225 across all filing types
Latest filing 2022-03-10 Transaction in Own Shar…
Country KR South Korea
Listing KO 007570

About ILYANG PHARMACEUTICAL CO.,LTD

https://www.ilyang.co.kr

Ilyang Pharmaceutical, established in 1946, is a research-oriented company that develops and manufactures a diverse portfolio of pharmaceutical products. The company focuses on developing new chemical entities (NCEs) and produces a range of medicines targeting digestive, respiratory, and circulatory system disorders, as well as neoplasms and infectious diseases. Key developments include 'Ilaprazole' (Noltec), a proton pump inhibitor for acid-related disorders, and 'Supect' (Radotinib), a treatment for chronic myeloid leukemia. Its product line also encompasses general drugs, antibiotics, anti-inflammatory agents, nutritional supplements, and well-established consumer health brands like the digestive aid 'NORUMO' and the nutritional drink 'Wonbi-D'.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a direct report of a company's decision to buy back its own shares through a trust, which falls under the category of 'Transaction in Own Shares'.
2022-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the change in share ownership by an executive (Kim Jun-gyeom) due to retirement. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report, as it tracks insider transactions and changes in holdings by company directors and executives.
2022-02-15 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from Il-Yang Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the dividend total, the record date (2021-12-31), and the board resolution date. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2022-02-07 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Disclosure' (영업(잠정)실적) from Il-Yang Pharmaceutical. It provides a summary table of key financial metrics (revenue, operating profit, net income) for the 4th quarter and cumulative annual figures. This is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q4 2021
2022-02-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service (국민연금공단) regarding their stake in Il-Yang Pharmaceutical (일양약품). This is a standard regulatory filing in South Korea (DART system) used to notify the market when a major shareholder crosses a reporting threshold (in this case, a decrease in ownership). This falls under the 'Major Shareholding Notification' category.
2022-01-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by an executive (Jung Yu-seok) of ILYANG PHARMACEUTICAL CO., LTD. This type of filing is a standard regulatory requirement for reporting insider trading or changes in share ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2021-11-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.